ARCH Venture Management, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$230.2B
Holdings
9
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BEAMBEAM THERAPEUTICS INC. | 4,540,132 | $112.6B | 48.91% | |
| 2 | RAPPRAPPORT THERAPEUTICS, INC. | 3,728,738 | $66.1B | 28.73% | |
| 3 | ERASERASCA, INC. | 11,055,554 | $27.7B | 12.05% | |
| 4 | VERVVERVE THERAPEUTICS, INC. | 2,008,809 | $11.3B | 4.92% | |
| 5 | GOSSGOSSAMER BIO, INC. | 8,055,916 | $7.3B | 3.17% | |
| 6 | —SINGULAR GENOMICS SYSTEMS, INC. | 126,630 | $2.5B | 1.07% | |
| 7 | QTTBQ32 BIO INC. | 320,482 | $1.1B | 0.48% | |
| 8 | UNBXUNITY BIOTECHNOLOGY, INC. | 1,004,817 | $981.1M | 0.43% | |
| 9 | —CERO THERAPEUTICS HOLDINGS, INC. | 9,393,561 | $563.6M | 0.24% |